News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Anticipating the Disruption from HIPAA 5010 Forms and ICD-10: Essential Action Steps to Maintain Your Lab’s Cash Flow

How to stay ahead of the biggest changes to claims submission
and reimbursement processes in the past 20 years

LIVE AUDIO AVAILABLE

Lale White

YOUR PRESENTERS:

Lâle White, CEO, Xifin, Inc.

Lee Ann Nichols, Chief Business Officer, West Pacific Medical Laboratory

(Moderator), THE DARK REPORT

LIVE Recordings – Order NOW!

Attention all labs: There’s a major deadline looming. Conversion to HIPAA 5010, the new form for electronic healthcare transactions, must be completed by January 1, 2012. That’s less than eight months from today.

This revised form accommodates the new ICD-10 codes, which represent an even bigger change in how your lab submits claims and which take effect in 2013.

Form 5010 must be in place, fully tested and ready to go, before ICD-10 codes can be implemented. No small feat, given the scope of the changes to come. And if you think your laboratory has plenty of time to prepare, think again.

There’s software to update, staff to train, and significant changes that your lab will need to make to its procedures and materials. Not to mention taking steps to ensure that you and everyone on your team understand exactly what it means to be 5010-compliant.

Recent studies indicate that both individual laboratories and the healthcare industry are far less prepared than they should be. But waiting is risky, so why take the chance that your lab will be caught short when the deadlines roll around?

What’s at risk if you’re not ready? Your lab’s revenue and timely reimbursements from Medicare carriers and private payers. Without the ability to use the new 5010 form and the new ICD-10 codes, you can pretty much guarantee a hefty increase in your lab’s rate of claim denials. That means extra work to resubmit these claims, then additional weeks or even months of waiting for your lab to finally get paid.

Find out how you can protect your lab’s revenue when you join The Dark Report and DarkDaily.com on Tuesday, May 24, 2011 for a very timely audio conference about the new 5010 form and ICD-10 codes. Listen as Lâle White, CEO at Xifin, Inc., provides you with a 5010 compliance readiness timeline. You’ll learn:

  • Specific action steps your laboratory should take.
  • How to assess your lab’s readiness for 5010 implementation.
  • “Must-achieve” benchmarks to ensure your lab meets the January 2012 deadline for 5010 compliance.

You’ll also get practical insights from Lee Ann Nichols, Chief Business Officer at West Pacific Medical Laboratories (WPML), who will share their experiences and lessons learned as her lab prepares to be fully compliant for 5010 in January 2012, followed by ICD-10 in 2013.

Adding to the burden of implementation is the fact that the number of ICD-10 codes is expected to increase from 17,000 to more than 75,000. But there is some good news in all of this: because ICD-10 includes codes for many new healthcare diagnoses and procedures, they’ll add precision to the bills your lab submits to payers for new genetic and molecular tests.

But it’s not just labs that will need to be ready for this explosion of codes. Your lab won’t get paid unless its physician-clients are prepared as well. That means developing a strategy to ensure that your doctor clients-and their staffs-are well versed in the correct codes and can submit accurate test orders to your lab that include the appropriate ICD-10 codes.

This audio conference is designed to help your laboratory get a head start on preparations. The one-two implementation of 5010 forms in 2012 and ICD-10 in 2013 raises the stakes for your laboratory to submit clean claims and get timely reimbursement from Medicare carriers and private payers.

Here’s where this audio conference pays for itself many times over: it will help you better assess the readiness of your key payers and vendors, and give you tips on how to interact with these payers so that your lab’s 5010 submissions are accepted and processed in a timely manner. It’s an important management strategy that will protect your lab’s cash flow.

And because payers are struggling to get ready for 5010 claims submissions, many of them could prove to be an obstacle in transitioning to the new forms. You’ll learn proven strategies your laboratory can use in response to payers who lag behind in 5010 preparedness.

Because this audio conference is about how your laboratory submits its claims-and how quickly payers reimburse you-it’s a “must-attend” event. And remember that you can have everyone on your lab team participate with you. For just one registration, you can all listen, learn, and get personalized answers to questions about your lab’s unique needs. Order recordings today to guarantee your place at this invaluable learning session.

THE DARK REPORT AUDIO CONFERENCE AT A GLANCE

 

COST: $245 per recording

TO ORDER NOW: Click here or call 1-800-560-6363 toll-free


For one low price—just $245
—you and your entire team can take part in this fast-paced, insightful audio conference. Best of all, you’ll be able to listen i to either of the panelists when we open up the phone lines for live Q&A and you can hear the same questions asked that you may have.

Here’s just some of what you’ll learn during this in-depth 90-minute audio conference recording:

  • How to assess your lab’s readiness for 5010 implementation.
  • Using the right checklists to prepare your lab’s coding, billing, and collections workflow to properly support the HIPAA 5010 form.
  • Easy ways to avoid the most common problems.
  • What you need to know to protect your lab’s cash flow as payers struggle with their own 5010 adoption issues.
  • Tools to decipher the rhetoric on 5010 and ICD-10.
  • A set of metrics and milestones to use during implementation.
  • How to assess your vendors’ preparedness.
  • Why 5010 is the “easy” implementation compared to the challenges associated with ICD-10 adoption.
  • The possible consequences of missing the deadline.

…and much more!

How to Order Now:

1. Online
2. Call toll free: 800-560-6363.

Your audio conference order includes:

  • A downloadable PowerPoint presentations from our speakers
  • A full transcript emailed to you soon after the conference

ORDER Now! Or for more information, call us toll-free at 800-560-6363

Distinguished Faculty:

Lâle White co-founded XIFIN in 2001 and serves as its CEO. She is a nationally recognized expert in the field of medical financial management and regulatory compliance, with more than 25 years’ experience in information systems development and medical billing. Ms. White has consulted for major laboratories and associations throughout the U.S. and worked with HCFA and the U.S. OIG to develop the first OIG Model Compliance Program. She previously served as VP-Finance at LabCorp, one of the largest clinical reference laboratories in the U.S. Ms. White has a BA in finance and an MBA from Florida International University.

Lee Ann Nichols is the Chief Business Officer of West Pacific Medical Laboratory where she is in charge of all operations for the company’s Orange County and Inland Empire divisions and is responsible for accounts receivable, human resources and client services, company-wide. Ms. Nichols is an expert in laboratory billing and operations, more than 25 years’ experience. Previously, she served as Director, Molecular Diagnostic Services, at XIFIN, Inc., and as Vice President of Accounts Receivable at Westcliff Medical Laboratory.

ACCENT® Continuing Education Credit
The American Association of Clinical Chemistry (AACC) designates this program for a maximum of 1.5 ACCENT® credit hours towards the AACC Clinical Chemist’s Recognition Award. AACC is an approved provider of continuing education for clinical laboratory scientists in the states of California, Florida, Louisiana, Montana, Nevada, North Dakota, Rhode Island, and West Virginia.

She is a member of DxMA, ASM and AMP and was a Microbiology Supervisor before transitioning to the diagnostic industry.”
;